402 Evaluating Surgical Outcomes of Patients with Metastatic Bone Disease Managed with Urgent Elective versus Emergent Surgical Care Pathways

501 STimulator of INterferon Genes (STING) Activation as an Immunogenic Therapy for Undifferentiated Pleomorphic Sarcoma

P0191 Evaluating Standard of Care Practice Patterns for Postoperative Metastatic Bone Disease Patients